TAMPA, Fla.--(BUSINESS WIRE)--DataLink Software (DataLink), a leading solutions provider that delivers interoperability, reduces costs and improves quality scores and risk...
Florida’s Health First is Already Enhancing Digital Patient Access Through the Integration BOSTON--(BUSINESS WIRE)--Kyruus, the leader in provider search and...
SarahCare Founder to Continue Its Mission to Provide Supportive Adult Day Care Under Innovative MedTech Umbrella BLUE ISLAND, IL /...
LAS VEGAS, NV / ACCESSWIRE / April 13, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
LOS ANGELES, CA / ACCESSWIRE / April 13, 2021 / Radiko Holdings (CSE:RDKO) (the "Company") announced today that La Vida...
VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / April 13, 2021 / Ovation Science Inc. (CSE:OVAT)(OTCQB:OVATF)("Ovation" or the "Company"), a topical...
TORONTO, ON / ACCESSWIRE / April 13, 2021 / Sparta Group (TSX.V:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital",...
FT. MYERS, FL / ACCESSWIRE / April 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global...
As one of the nation’s leading strategic pharmacy economics experts, XIL Health provides actionable insights to encourage organizations, including retail...
SEATTLE, April 13, 2021 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company that pre-tests drugs on patient-derived live tumor...
TORONTO, April 13, 2021 (GLOBE NEWSWIRE) -- Dimensions Health Centres (“Dimensions”), a psychedelic treatment company, officially announced the company formation...
WESTMINSTER, Colo., April 13, 2021 (GLOBE NEWSWIRE) -- We are developing the infrastructure of a global zoonotic infectious diseases “alert...
Resonant’s Intellectual Property Portfolio Increases to Over 320 Patents Issued and PendingAUSTIN, Texas., April 13, 2021 (GLOBE NEWSWIRE) -- Resonant...
BOSTON, April 13, 2021 (GLOBE NEWSWIRE) -- Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential...
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”),...
EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies...
– Appointment strengthens leadership team as the Company readies for potential global odevixibat launch and progresses multiple clinical development programs...
Collaboration combines Senti Bio’s leading-edge gene circuit technology platform and high-throughput synthetic promoter design capabilities with Spark Therapeutics’ investigational gene...
Phase 1b/2a Study Expected to Begin In 2Q 2021DELRAY BEACH, Fla., April 13, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc....
- Collaboration combines Senti Bio’s leading-edge gene circuit technology platform and high-throughput synthetic promoter design capabilities with Spark Therapeutics’ investigational...